Wyden seeks federal investigation into anti-competitive drug industry practices
The Office of US Sen. Ron Wyden | Dec 7, 2021 | Oregon
HCPF report offers data-driven solutions to high Rx prices
Eli Kirshbaum | Jan 13, 2021 | Colorado
AARP applauds passage of bills aimed at lowering the cost of prescription drugs
Michael Goldberg | Mar 9, 2020 | Washington
Oregon health bills to watch
Emily Boerger | Jan 30, 2020 | Oregon
DCBS releases prescription drug price transparency annual report
Emily Boerger | Dec 19, 2019 | Oregon
The Department of Consumer and Business Services (DCBS) recently released the Oregon Prescription Drug Price Transparency Program’s 2019 Annual Report. The report details information from drug manufacturers, health insurance companies, and consumers on prescription drug pricing, price increases, and the impacts these drug prices have on Oregonians. DCBS